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ABSTRACT
Background: Miller fisher syndrome is generally considered a rare but important variant of Guillain Barré Syndrome
(GBS) having geographically variable incidence. Patients with this clinical syndrome are often misdiagnosed and
mismanaged due to lack of awareness on the part of physician. Objective: To determine frequency of Miller fisher
syndrome (MFS), variant of GBS in patients presenting to a tertiary care hospital in Karachi. Methods: This descriptive
cross sectional study was conducted in the Department of Neurology, Jinnah Postgraduate Medical Centre (JPMC),
Karachi. The duration was from April, 2014 to April, 2016 (two years). A total of 100 patients were included in this
study. Patients were classified into GBS, MFS and GBS/MFS overlap according to their clinical presentation, CSF
analysis and electrophysiological findings. Data was collected on a predesigned proforma. Results: Out of 100 cases,
62 (62%) were males and 38 (38%) were females. Frequency of Miller fisher syndrome (MFS) in patients of GBS was
14% predominantly involving male, with male to female ratio is 6:1.Majority of patients had duration of symptoms for
11 ± 6 days before presentation. The mean age of patients with MFS was 46.03years (SD±12.6). Conclusion: We
report a high frequency of MFS in our population with predominant involvement of male gender.
Keywords:
Frequency, GBS, Miller fisher syndrome, Tertiary Care
INTRODUCTION:

complain of difficulty in walking, maintaining balance,
coordination and blurring of vision. MFS has a higher
incidence in Asia, where the incidence is estimated to
be 18%–26% of GBS compared with 3%–5% in the
Western countries like Europe.[3,4] MFS occurs more
frequently in men than women by a ratio of
approximately 2:1 [3]. The onset of MFS varies from 13
to 78 years of age with a mean of 43.6 years [3]. The
typical patients usually do not have motor weakness,
but they can present with motor weakness like GBS
called Overlap syndrome [5]. Some time patients may
present without ataxia or ophthalmoplegia called
incomplete form of MFS [5].

GBS is an acute immune-mediated polyneuropathy
characterized by rapidly evolving, symmetrical, often
ascending limb weakness and loss of deep tendon
reflexes. It is a heterogeneous condition with several
variants forms including regional, functional and
electrophysiological.[1,2] In typical cases, the first
symptoms of GBS are pain, numbness, paresthesia,
and weakness in the limbs, however it can also present
without weakness. MFS is one of the examples of such
variants.
In 1956, Dr. Charles Miller Fisher described three
patients with the clinical triad of ophthalmoplegia,
ataxia and areflexia without prominent signs of
peripheral neuropathy.[3] These patients usually
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The pathogenesis of MFS is characterized by the
presence of serum monoclonal antibodies anti-GQ1b
that can bind to human peripheral nerves,
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SUBJECTS AND METHODS:

predominantly oculomotor nerves.[6] Antibodies to
GQ1b are most likely induced during the infection
preceding the onset of neurological symptoms[3].
Campylobacter jejuni isolates from MFS patients have
been identified which contain lipo-oligosaccharides
showing molecular mimicry with GQ1b antibodies and
other gangliosides,which can cross-react to GQ1b and
other gangliosides in peripheral nerves.[3,6]

This study was conducted at the Department of
Neurology, JPMC, Karachi over a period of two years
(April 2014-16). We enrolled 100 patients in our study.
Patients aged 14 years and above, regardless of their
gender with history of < 4 weeks duration of difficulty in
walking and evidence of hyporeflexia/areflexia on
clinical assessment were included in this study.
Patients were classified into MFS according to their
clinical
presentation
(areflexia,
ataxia
and
ophthalmoplegia), lab parameters like CSF with
albuminocytological dissociation and electrophsiolology
showing decreased or absent sensory nerve action
potentials (SNAP). Exclusion criteria included history of
exposure to toxins, presence of upper motor neuron
signs, Brain-stem stroke, Wernicke’s encephalopathy
and myasthenia gravis. These patients were excluded
on the basis of clinical history, neurological examination
and relevant investigations including neuroimaging
where indicated. Vitamin B12 deficiency and Diabetes
mellitus were also ruled out in suspicious cases of
ataxia with absent reflexes. A questionnaire was
designed to collect data. Verbal informed consent was
taken prior to enrollment in study. All patients were
reviewed by consultant neurologist. Bias was controlled
by having the CSF detailed reports and nerve
conduction studies by same lab and same investigator.
We offered Plasmapheresis to all patients diagnosed
with MFS/ GBS as a treatment option. Data analysis
was done with the help of statistical package for social
sciences (SPSS) version 17. Descriptive statistic was
applied on demographic variables like age and gender.

Anti-GQ1b IgG antibodies may also be found in patients
with acute ataxia (without ophthalmoplegia), acute
ophthalmoplegia
(without
ataxia),
GBS
with
ophthalmoplegia, lower bulbar variant of GBS and
Bickerstaff encephalitis [6,].
On Electrophysiological studies the most consistent
findings in MFS are reduced sensory nerve action
potentials and absent H reflexes.[7] Other findings on
further
investigation
are
albuminocytological
dissociation on CSF studies and contrast enhancement
of nerve roots in few cases.[8]
Most patients with MFS show a monophasic and
benign course of disease leading to complete remission
without residual deficits [9]. Most patients
spontaneously start to improve within 2 to 4 weeks
after onset of neurological symptoms. The recovery
usually is completed after weeks to months with a
mean recovery time of 10 weeks [9]. These clinical
presentations can occur in other neurological disorder
so careful clinical assessment and focused
investigations
such
as
brain
imaging
and
electrophysiological examinations can rule out other
conditions. The differential diagnosis of MFS includes
Wernicke's encephalopathy, myasthenia gravis,
botulism, and brainstem stroke.

RESULTS
A total of 100 patients were included in this study. The
average age of the patients was 36.03±12.62 years
with 62% were males and 38% were females. Majority
of patients had symptoms before hospitalization for 11
± 6 days.

MFS is considered to be a variant of GBS because they
share the presence of
•
•
•
•
•
•

Areflexia essential for the diagnosis of GBS
Increased protein levels in absence of increased
cells in cerebrospinal fluid
Usual monophasic course of disease,
Antecedent infection,
Anti-ganglioside antibodies in serum and
Presence of cross-over cases in which MFS
patients may progress to GBS.

Frequency of Miller fisher syndrome (MFS) was found to
be 14%, 12 patients (86%) were male and 2 patients
(14%) were female. The mean age of the patients with
MFS was 46.03 years (SD±12.6).It was significantly
high in patients above 50 years of age. Effect of
duration of disease was not significant. It was also
observed that out of 14 patients, 2 patients (14%) had
incomplete MFS i.e. only ophthalmoplegia and areflexia
while 4 patients (28%) had overlap syndrome i.e.
gradually developed generalized weakness.

The Miller Fisher syndrome appears to be more
common in eastern Asia than among those who live in
other parts of the world [4, 5]. There is limited data on the
frequency of MFS in Pakistan. The aim of our study was
to find out the frequency of MFS in our setup.
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Out of 14 patients 11 underwent Plasmapheresis, 3
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age after first decade of life.[5]

refused for that and left against medical advice. All
patients
were
improved
during
course
of
Plasmapheresis and advised for follow up after 3
months. Seven patients lost follow-up after discharge
and remaining 4 patients completely improved after 3
months. Improvement on treatment strengthens our
diagnosis.

Review of literature showed, MFS a variant of GBS
accounts for 5% of cases in Western Europe though
prevalence might be higher in other areas, such as
reported from Eastern Asia countries like Taiwan and
Japan.[4,9].keeping in view we also suspected high
frequency of MFS in our country.

Frequency of Miller Fisher Variant of Gbs with Respect
to Age Group

To our knowledge this is the first study conducted on a
relatively large number of patients in Pakistan showing
that MFS in our population is 14%, which is higher as
compared to western countries where it is 5%. [4,5,9]Our
results are comparable with a study conducted in
Taiwan which showed frequency of MFS as 20%. [10]
while similar study in Japan also showed same results.
[9]
According to one study it is about 5% to 7% in
western countries and 20 to 25% in Asian [5]. In Taiwan,
another study showed 11 of 60 patients with GBS had
MFS (18%).[11]
A recent analysis of 32 years in Hong Kong reported 9%
and 7.7% in Thailand [12]. In a Spanish case series, 8
of 69 patients with GBS had MFS (11.5%) [13].

Frequency of Miller Fisher Variant of Gbs with Respect
to Gender

Stratification analysis with respect to age was observed
and rate of MFS was significantly higher in above 50
years of age. The mean age of patients in our study was
46 years (SD±12.6). One study showed that the mean
age of onset of MFS is 43.6 years[4] though onset has
been documented in individuals between the ages of
13 and 78 years.[9] Another study also showed mean
age of 44 years[8]. In our study, MFS was more common
in males as than females with 6:1 ratio respectively.
Other studies also showed that MFS occurs more in
men than women with ratio of 2:1[4, 14] but this ratio is
less as compared to our study. Considering the
supposed autoimmune etiology of GBS and MFS, the
male preponderance is somewhat unexplained.

MILLER
M
F
FISHER
SYNDR
ROME

Gendeer
Malee
Femalle

Yes
Y

No

n=
=14

n=86

Tootal

12 (86%)
(

50 (58%
%)

6
62

2 (1
14%)

36(42%
%)

3
38

Chi-Squuare=3.88;p=
=0.049
syndrome. New Engll J Med. 20112;366(24):22294–304.

It was also observed that out of 14 patients, 2 patients
(14%) presented with incomplete MFS having only
ophthalmoplegia and areflexia while 4 patients (28%)
presented with overlap syndrome having generalized
weakness. In comparison to other study which showed
that half of the patients with MFS eventually
experienced profound weakness (overlap syndrome)
[15]
.

DISCUSSION:
GBS is a common cause of acute flaccid paralysis
worldwide. The overall incidence of GBS is found to be
1.1 to 1.8/100,000 population.[4,5] Our study showed
that GBS is more common in males as compared to
females. The relative risk for men is 1.78 compared to
women in different studies [4, 5]. Male preponderance is
especially seen in older patients. In our study, the
average age of the patients with GBS was
36.03±12.62 years. Different studies showed
increase incidence of GBS with every 10 year rise in
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CONCLUSION:
In conclusion, our study demonstrated incidence and
sex distribution of GBS similar to many other previous
studies. The frequency of MFS in patients of GBS in our
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study was found to be 14%, with predominantly
involving male gender. High clinical suspicion is needed
to diagnose MFS because all symptoms may not
appear at the same time. Clinicians must remember
this important variant while evaluating atypical
combination of areflexia, ophthamoplegia and ataxia,
so that patients with these clinical presentations are
not misdiagnosed and mismanaged and they can offer
better care to their patients. Due to lack of data further
studies are recommended in Pakistan to strengthen
results of our study on this topic.
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LIMITATION:
We diagnosed MFS on clinical basis and investigations
like CSF analysis and NCS. More relevant investigation
like anti-GQ1b antibodies level was not done because
of financial constraints. All patients were treated with
Plasmapheresis and IVIg was not given as a treatment
option because of same reasons.
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